The Centers for Medicare & Medicaid Services (CMS) implemented a new opioid policy for Medicare drug plans on January 1. The new policies include:

  • Improved safety alerts when patients fill opioid prescriptions at the pharmacy
  • Drug management programs for patients at-risk for misuse or abuse of opioids or other drugs

CMS posted new training materials, including slide decks and tip sheets for prescribers, pharmacists and patients.

CMS also recently released an MLN Matters® Article: A Prescriber’s Guide to the New Medicare Part D Opioid Overutilization Policies for 2019. Visit the Reducing Opioid Misuse webpage for more information on CMS’ overall strategy.

Contact Us

Contact Biddy Smith at 1.800.642.8686, ext. 3252

or visit us online at

This material was prepared by Quality Insights, the Medicare Quality Innovation Network-Quality Improvement Organization for West Virginia, Pennsylvania, Delaware, New Jersey and Louisiana under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services. The contents presented do not necessarily reflect CMS policy.